Forte Biosciences Inc
NASDAQ:FBRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Forte Biosciences Inc
NASDAQ:FBRX
|
US |
|
B
|
Banca Mediolanum SpA
OTC:BNMDF
|
IT |
|
ADVFN PLC
LSE:AFN
|
UK |
|
B
|
BSF Enterprise PLC
LSE:BSFA
|
UK |
|
D
|
Dalipal Holdings Ltd
HKEX:1921
|
CN |
|
I
|
InterContinental Hotels Group PLC
NYSE:IHG
|
UK |
|
G
|
Gratomic Inc
OTC:CBULF
|
CA |
|
Riedel Resources Ltd
ASX:RIE
|
AU |
|
Alstom SA
PAR:ALO
|
FR |
|
P
|
Pfizer Inc
XBER:PFE
|
US |
|
Fairfax Financial Holdings Ltd
TSX:FFH
|
CA |
|
SmileDirectClub Inc
OTC:SDCCQ
|
US |
|
I Grandi Viaggi SpA
MIL:IGV
|
IT |
|
Coca Cola HBC AG
LSE:CCH
|
CH |
|
A
|
Albireo Pharma Inc
F:BDQM
|
US |
|
A
|
Adecco Group AG
SIX:ADENE
|
CH |
|
PostNL NV
AEX:PNL
|
NL |
|
Z
|
Zumtobel Group AG
VSE:ZAG
|
AT |
|
Canoo Inc
NASDAQ:GOEV
|
US |
|
Tamarack Valley Energy Ltd
TSX:TVE
|
CA |
|
Cheniere Energy Inc
NYSE:LNG
|
US |
|
CarGurus Inc
NASDAQ:CARG
|
US |
|
JCDecaux SE
PAR:DEC
|
FR |
|
Isetan Mitsukoshi Holdings Ltd
OTC:IMHDF
|
JP |
Bankruptcy Probability
Forte Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Forte Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Forte Biosciences Inc
NASDAQ:FBRX
|
400.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Forte Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Forte Biosciences Inc has no debt.
You can find a full breakdown on its Balance Sheet.
